Biocatalysis with nicotinamide adenine dinucleotide phosphate(NADP)-dependent oxidoreductases faces a challenge in improving the efficiency of the costly cofactor utilization.Although enzyme fusion can offer cofactor ...
the financial support from the National Natural Science Foundation of China(22174119 and 21974115);the Fundamental Research Funds for the Central Universities(20720210001 and 20720220005);the Program for Changjiang Scholars and Innovative Research Team in University(IRT_17R66);the Foundation for Innovative Research Groups of the National Natural Science Foundation of China(21521004)to C.Wu;the University Innovation Group Program of Jinan(202228080);the Shandong Provincial Natural Science Foundation(ZR2021JQ30);the Taishan Scholar Program of Shandong Province(tsqn201909004)to D.Wu.
Utilizing diverse organic crosslinkers for cyclization has proven to be an effective approach to creating peptide libraries;enabling the rapid discovery of functional peptides.Existing crosslinkers usually provide a t...
supported by the National Key Research and Development Program of China(2023YFF1103802)。
The anti-inflammatory properties of silkworm pupa peptide(SPP)have been recognized for their potential benefits in colitis treatment.However,the underlying mechanism of SPP in colitis animal models remains unclear.The...
supported by CAMS Innovation Fund for Medical Sciences(No.2021-I2M-1-026,China).
Gliomas are the most common intracranial tumors with poor survival and high mortality.Furthermore,the clinical efficacy of current drugs is still not ideal;despite the development of several therapeutic drugs over the...
supported by the National Key R&D Program of China(2022YFA1205701 and 2020YFA0210800);the National Natural Science Foundation of China(52322308,51725302,52273126,11621505,and 82302266);Beijing Nova Program(20230484237);the Strategic Priority Research Program of the Chinese Academy of Sciences(XDB36000000);the Key Research and Development Program of Heilongjiang Province(2022zX06004);Hong Kong scholar project(Xj2024052);Harbin Medical University Cancer Hospital Haiyan Foundation(JYQ2024-03 and JZD2024-17);the Nn10 program of Harbin Medical University Cancer Hospital(Nn102024-01);the Climing program of Harbin Medical University Cancer Hospital(PDYS2024-03);China Postdoctoral Science Foundation(2024MD753933);Heilongjiang Postdoctoral Fund(LBH-Z23221).
Tumor metastasis accounts for over 90%of tumor-related deaths,prompting the development of fluorescently labeled tumor-specific molecular imaging agents for differentiating tumors from normal tissues.However,early det...
supported by the National Natural Science Foundation of China(Grant No.81971965)。
Ischemia-reperfusion injury(IRI)remains an unavoidable challenge in liver surgery,with macrophages playing a critical role in its pathogenesis.However,the mechanisms by which macrophages regulate the pathogenesis of I...
Momordica antiviral protein 30 kD(MAP30)is a type I ribosome-inactivating protein(RIP)with antibacterial,anti-HIV and antitumor activities but lacks the ability to target tumor cells.To increase its tumor-targeting ab...
supported by the National Natural Science Foundation of China(No.82372002);the Nonprofit Central Research Institute Fund of the Chinese Academy of Medical Sciences(No.2022-RC350-04,China);the CAMS Innovation Fund for Medical Sciences(Nos.2021-I2M-1-026(2023),2022-I2M-2-002-2,and 2021-I2M-3-001(2023),China);the National Key Research and Development Program of China(No.2022YFE0111700);the Beijing Nova Program to Kuan Hu(No.0104002,China);supported by the Beijing Natural Science Foundation(No.L234044,China);the Fundamental Research Funds for the Central Universities(Nos.3332023044 and 3332023151,China);the CIRP Open Fund of Radiation Protection Laboratories(No.ZHYLYB2021005,China);the China National Nuclear Corporation Young Talent Program.
Peptide-based radiopharmaceuticals targeting integrinα5β1 show promise for precise tumor diagnosis and treatment.However,current peptide-based radioligands that targetα5β1 demonstrate inadequate in vivo performanc...
supported by the National Natural Science Foundation of China(No.31872547);the Natural Science Foundation of Zhejiang Province,China(No.LTGN24C190015);the Excellent Postdoctoral Program of Jiangsu Province(No.314865)。
The novel identified receptor,GPR103,now renamed QRFPR(also referred to as SP9155 or AQ27),is the endogenous receptor for the neuropeptide QRFP(also referred to as 26RFa).The distribution pattern,structure,and biologi...